Kin Health | $9,000,000 | (May 20, 2026)
Scope AI | $20,000,000 | (May 20, 2026)
Leadbay (YC F25) | $4,300,000 | (May 20, 2026)
Certified by Founder
Lodge
Mozart Therapeutics, Inc
start up
United States
- Seattle, WA
- 08/06/2023
- Series A
- $25,000,000
Mozart is developing disease-modifying therapies for autoimmune and inflammatory diseases that work by targeting a novel regulatory immune pathway.
- Industry Biotechnology Research
- Website https://www.mozart-tx.com/
- LinkedIn https://www.linkedin.com/company/mozart-therapeutics/
Hellbender Inc. | $12,500,000 | (May 20, 2026)
Rely | $4,500,000 | (May 20, 2026)
bunch | $35,000,000 | (May 20, 2026)
Vital Signals | $15,000,000 | (May 20, 2026)
viktor.com | $75,000,000 | (May 20, 2026)
Brami Inc. | $33,000,000 | (May 20, 2026)
Benji | $6,250,000 | (May 20, 2026)
Hacktron AI | $2,900,000 | (May 19, 2026)
Elliptic | $120,000,000 | (May 19, 2026)